Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-B7 H1 and anti-CTLA-4 antibodies for treating non-small cell lung cancer

Anti-B7 H1 and anti-CTLA-4 antibodies for treating non-small cell lung cancer

US Patent 10232040 · Granted Mar 19, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Integrated circuit with supply voltage detector2025
Analog voltage regulator with reference modulation2025
Parenterally administered immune enhancing drugs2025
Methods for determining treatment for cancer patients2025
Anti-B7-H1 antibodies for treating tumors2023
Anti-B7-H1 antibodies for treating tumors2023
Methods for determining treatment for cancer patients2023
Dosing with an azolopyrimidine compound2022
Anti-B7-H1 and anti-CTLA-4 antibodies for treating non-small cell lung cancer2022
Anti-B7-H1 and anti-CTLA-4 antibodies for treating non-small cell lung cancer2022
Anti-B7-H1 and anti-CTLA-4 antibodies for treating non-small cell lung cancer2022
Anti-B7-H1 and anti-CTLA-4 antibodies for treating non-small cell lung cancer2022